logo
Mind Over Money: Emotional Intelligence is the new leadership edge — and women are already there

Mind Over Money: Emotional Intelligence is the new leadership edge — and women are already there

Economic Times07-06-2025
Women Leaders Show Greater Openness and Awareness
Live Events
Both Genders Focus on Mental Fitness — But Differently
Neuroscience Provides Data-Driven Clarity
A Shift Toward Intentional Mental Fitness Across Genders
(You can now subscribe to our
(You can now subscribe to our ETMarkets WhatsApp channel
But when it comes to leaders, are women more aware and engaged in this space than their male counterparts? ETMarkets spoke to a range of experts — from psychosomatic healers and executive coaches to neuroscientists — to understand whether women leaders are indeed more aware of their mental health needs compared to their male counterparts.Their answers reveal a nuanced but consistent pattern: women not only talk more about mental fitness but also take deliberate steps to build it into their lives and leadership styles.According to Kaajal Desai, Transformation Coach and Psychosomatic Healer, women are more inclined toward self-reflection and communication when it comes to their mental health.'Women tend to be more aware of mental health compared to men. They are often more open to self-reflection, communication, and proactive in utilizing tools to maintain good mental health,' says Desai.While this doesn't necessarily mean they are always in better mental health, their willingness to engage with it is often higher. Desai also notes that many women leaders embrace a transformational leadership style — emphasizing collaboration, emotional intelligence, and well-being.With over 2,500 hours of coaching under her belt, Desai highlights that 95% of her coachees are women — including those in senior management roles.'The multiple roles that women play in their personal and professional lives often lead them to seek support through counseling or coaching,' she adds.Amit Vip, an Executive & Business Coach and former MD at a multinational bank, offers a nuanced view based on his coaching experience.'Both men and women leaders have an increasing level of focus on mental fitness, though women tend to talk about it more and explore different ways to stay mentally fit,' he notes.Women often engage in activities such as singing, dancing, journaling, or decluttering — acts that promote emotional regulation and relaxation. Men may prefer more structured or performance-oriented methods. Vip points out that while approaches may differ, mental fitness is now on the radar for leaders across the board.Bringing a scientific lens to the conversation, Kumaar Bagrodia, Founder of NeuroLeap, shares insights from over 20,000 brain assessments conducted using neurotechnology.'Women leaders often show a higher degree of awareness and engagement with their mental health compared to their male counterparts,' says Bagrodia.He attributes part of this difference to brain network dynamics — particularly the Default Mode Network (DMN), which is more active in women and linked to self-reflection. While this connectivity can sometimes lead to emotional rumination, when trained and harnessed, it gives women a 'metacognitive edge.'Women also score higher on interoceptive awareness — the ability to sense internal bodily states — and are generally more willing to seek professional help.'They're not necessarily less stressed—but they are often more intentional about managing it,' Bagrodia explains.Interestingly, he notes that when male leaders do engage in mental fitness practices, the transformation can be equally profound — especially when they view mental well-being as a performance enabler rather than a sign of weakness.The consensus among experts is clear: while women leaders may be more vocal and proactive about mental fitness, the importance of emotional and psychological well-being is resonating across the leadership spectrum.Whether it's through journaling and coaching or neurofeedback and mindfulness, mental fitness is steadily becoming a core part of leadership development — not just for women, but for all leaders looking to thrive in a complex, fast-paced world.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Blue Jet Healthcare shares crash 10% post Q1 earnings. Here's what triggered the fall
Blue Jet Healthcare shares crash 10% post Q1 earnings. Here's what triggered the fall

Economic Times

time6 days ago

  • Economic Times

Blue Jet Healthcare shares crash 10% post Q1 earnings. Here's what triggered the fall

Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel Shares of Blue Jet Healthcare tanked 10% on Tuesday to hit the day's low Rs 90.6.15 on the NSE following the announcement of its Q1 earnings. The company reported a 17% drop in its sequential net profit to Rs 91 crore versus Rs 110 crore reported in company also reported a 4% decline in its June quarter revenues at Rs 355 crore as against Rs 340 crore reported in the corresponding quarter of the last financial selling pressure was seen despite a 141% surge in Blue Jet's profit after tax (PAT) on a year-on-year basis with the company reporting a bottom line of Rs 38 crore in Q1FY25. The topline increased by 118% on the YoY basis versus Rs 163 crore posted in the April-June quarter of FY25. Blue Jet Healthcare shares hit a 52-week high of Rs 1,027.80 on company's PAT decline could be attributed to a double-digit rise in its quarterly expenses on a QoQ and YoY basis. Blue Jet reported expenses of Rs 240 crore in the quarter under review, up 17% from Rs 205 crore in Q4FY25 and 97% from Rs 122 crore in the year-ago period. The expenses were made under the heads like 'Cost of Materials Consumed', 'Employee Benefits Expense', and 'Finance Cost', among other company is engaged in the manufacturing of artificial sweetener, contrast media intermediate, pharma intermediate, and APIs used in pharmaceutical and healthcare Jet Healthcare is a smallcap stock with a market capitalization of Rs 15,718.57. The stock has been a multibagger with 116% returns over a 1-year period. This stock has rallied 57% on a year-to-date basis notwithstanding today's sharp is currently trading above its 50-day and 200-day simple moving averages (SMAs) of Rs 884 and Rs 705, respectively, according to Trendlyne. The stock has also displayed high volatility in the past one year with a beta of read: IRFC stock tumbles 35% after 551% 3-year surge. What to do ahead of Q1 results?

ManipalCigna Health Insurance lines up aggressive expansion plan
ManipalCigna Health Insurance lines up aggressive expansion plan

Time of India

time17-07-2025

  • Time of India

ManipalCigna Health Insurance lines up aggressive expansion plan

Chennai: The ManipalCigna Health Insurance Company Ltd has planned to expand its footprint in Tamil Nadu with 10 more branches and add over 10,000 advisors across South India. ManipalCigna Health Insurance Company Ltd is a joint venture between Manipal Group, an eminent player in healthcare delivery and higher education and global health services company Cigna Healthcare. Citing a data from the General Insurance Council (GIC), ManipalCigna said it outpaced the sector with a 30 per cent growth in premium in Q1 FY2026 reflecting its strong regional strategy and customer-first product design. With 18 offices, a network of over 1,500 empaneled hospitals, and over 7,000 advisors ManipalCigna has covered more than 11 lakh lives in TN in FY2025. Commenting on the growing presence in the State, company's Chief Marketing Officer Sapna Desai said, "Over the years, our growing network, innovative offerings, and customer-centric approach have enabled us to earn the trust of our policyholders and our partners to deliver tangible value." "Our consistent growth and the launch of our innovative flagship product, 'Sarvah' with unique features such as infinite coverage available with 'Sarvah Uttam' plan and absolutely zero waiting period available with 'Sarvah Param' plan, demonstrates our dedication to the health, well-being of our customers," Desai said in a press release, here. Over the last three years, the company has settled claims worth Rs 101 crore in Tamil Nadu. In the first quarter of the current financial year, the company achieved a 30 per cent premium growth.

Sun Pharma shares in focus following US launch of LEQSELVITM, settlement with Incyte Corporation
Sun Pharma shares in focus following US launch of LEQSELVITM, settlement with Incyte Corporation

Time of India

time15-07-2025

  • Time of India

Sun Pharma shares in focus following US launch of LEQSELVITM, settlement with Incyte Corporation

Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel Shares of Sun Pharmaceutical Industries are expected to remain in focus on Tuesday, July 15, after the company announced two significant developments regarding its oral treatment for severe alopecia areata, LEQSELVITM (deuruxolitinib), in the United a regulatory filing on Monday, Sun Pharma informed that it has entered into a settlement and license agreement with Incyte Corporation about the litigation surrounding litigation had been pending before the United States District Court for the District of New Jersey. Under the terms of the agreement, both Sun Pharma and Incyte will mutually release each other from all claims that were raised or could have been raised in the part of the settlement terms, Incyte has granted Sun Pharma a limited, non-exclusive license, along with certain other related patents pertaining to oral deuruxolitinib for specific non-hematology-oncology indications, including alopecia areata, within the United consideration for the settlement and the license granted, Sun Pharma will make an upfront payment to Incyte, along with ongoing royalty payments that will continue until the expiry of the relevant patents. The company clarified that the other specific terms of the agreement remain parallel, Sun Pharma also announced the commercial launch of LEQSELVITM (deuruxolitinib) 8 mg tablets in the United States. According to the official announcement, the drug is now available nationwide for prescription to healthcare providers and patients suffering from severe alopecia areata, offering a new treatment option in this is indicated for the treatment of adult patients diagnosed with severe alopecia the importance of this launch, Sun Pharma stated that treatment options for patients living with severe alopecia areata in the U.S. remain limited, underscoring the need for therapies such as company further disclosed that the drug had demonstrated promising clinical trial results. Specifically, one-third of patients treated with LEQSELVITM regained almost all of their hair by Week 24 of 3% of patients achieved 80% or more scalp coverage in as early as eight weeks.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store